Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | AHR | P35869 | 8/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10575187 | 0.85 | TSHR (0.56) | TSHRAHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL30970438 | 0.85 | TSHR (0.56) | TSHRAHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL31393013 | 0.84 | TSHR (0.54) | TSHRAHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL31085108 | 0.84 | TSHR (0.54) | TSHRAHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7519328 | 0.82 | TSHR (1.00) | TSHRCYP1A2CYP2C9CYP2C19KIF11 | |
| SCHEMBL17171671 | 0.77 | TSHR (0.77) | TSHRCYP1A2CYP2C9CYP2C19KIF11 | |
| SCHEMBL361525 | 0.75 | TSHR (0.56) | TSHRAHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1752066 | 0.72 | AHR (0.48) | TSHRAHRKIF11NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL9873251 | 0.70 | TSHR (0.65) | TSHRCYP1A2CYP2C9CYP2C19KIF11 | |
| SCHEMBL8387152 | 0.69 | TSHR (0.43) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030134824-A1 | Beta-cyclodextrin dimers and phthalocyanines and uses thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030134824-A1 | Beta-cyclodextrin dimers and phthalocyanines and uses thereof | CRY2, CRY1, HCCS | TSHR 4690/4885AHR 1218/4885CYP1A2 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.